Key result
Older age and comorbidities show no independent link to severe complications after minimally invasive esophagectomy.
Why the study?
Perioperative risks in older, comorbid, and frail patients are increased for open esophagectomy, but remain uncertain for minimally invasive esophagectomy.
Does older age, comorbidity, or frailty increase the risk of severe complications after minimally invasive esophagectomy in adult esophageal cancer patients?
Cohort (n=245)
Yes
Does older age, comorbidity, or frailty increase the risk of severe complications after minimally invasive esophagectomy in adult esophageal cancer patients?
Older and comorbid patients do not experience higher rates of severe complications following minimally invasive esophagectomy, suggesting they are safe candidates for the procedure.
Answers are grounded in this paper and cite their sources.
Severe complications affect over one-third of patients; this Level 3 cohort study leaves open the identification of modifiable predictors.
Summary Background Perioperative risks in older, comorbid, and frail patients undergoing open esophagectomy are increased, whereas these risks remain uncertain for minimally invasive esophagectomy (MIE). This study investigates the relationship between age, comorbidity, frailty, and complications after MIE. Methods Prospective data from the randomized ICAN trial were used, which compared intrathoracic and cervical anastomosis in adult esophageal cancer patients undergoing MIE. Patients were categorized by age (<75 and ≥ 75 years), comorbidity (ASA, Charlson Comorbidity index (CCI), Cumulative Illness Rating Scale for Geriatrics (CIRS-G)), and frailty (TOPICS-MDS ≥0.20). Primary outcome: severe complications (Clavien-Dindo grade ≥ 3a). Secondary outcomes: overall complications, hospital and intensive care unit (ICU) length of stay (LOS), and hospital readmission. Multivariable regression analysis adjusted for gender and anastomosis location. Results Among 245 patients, 87 (35.5%) had severe complications. Eighteen (7.3%) were aged ≥75 years, 49 (20%) had ASA ≥3, 41 (16.7%) had CCI ≥2, median CIRS-G score was 3 (IQR 2.0), and 14 patients (5.7%) were frail. In multivariable regression, age, ASA ≥3, CCI ≥2, and CIRS-G were not independently associated with severe complications, overall complications, readmission, hospital or ICU LOS. Multivariable regression analysis for frailty was limited by the small number of frail patients. Conclusions Older and comorbid patients did not experience higher rates of severe complications following MIE, suggesting that they may be considered safe candidates for MIE despite their age. When selected according to current clinical practice, age, and comorbidity alone should not rule out surgical consideration.
No takes yet. Share an insight, caveat, or question.
Wissing et al. (2026) conducted a cohort in Esophageal cancer (n=245). Older age (≥75 years), high comorbidity, and frailty vs. Age <75 years, lower comorbidity, and non-frail was evaluated on Severe complications (Clavien-Dindo grade ≥ 3a). Older age (≥75 years) and comorbidities were not independently associated with the 35.5% overall rate of severe complications following minimally invasive esophagectomy.
Synapse has enriched 10 related papers. Consider them for comparative context: